BlackRock Fund Advisors - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 30 filers reported holding PSYCHEMEDICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2016$329,000
+30.6%
13,349
+5.2%
0.00%
Q3 2016$252,000
+39.2%
12,691
-3.8%
0.00%
Q2 2016$181,000
-33.0%
13,197
-32.9%
0.00%
Q1 2016$270,000
+25.0%
19,660
-7.7%
0.00%
Q4 2015$216,000
+2.9%
21,291
+1.9%
0.00%
Q3 2015$210,000
-28.1%
20,896
+6.2%
0.00%
Q2 2015$292,000
-18.9%
19,682
-9.3%
0.00%
Q1 2015$360,000
+2.6%
21,705
-6.4%
0.00%
Q4 2014$351,000
+15.1%
23,177
+7.7%
0.00%
Q3 2014$305,000
-6.7%
21,521
-6.8%
0.00%
Q2 2014$327,000
-14.8%
23,085
+2.9%
0.00%
Q1 2014$384,000
+21.9%
22,435
+4.6%
0.00%
Q4 2013$315,000
+15.8%
21,450
+4.4%
0.00%
Q3 2013$272,000
+44.7%
20,550
+17.2%
0.00%
Q2 2013$188,00017,5300.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 250,388$3,974,0004.46%
QUANTUM CAPITAL MANAGEMENT 63,246$1,004,0000.58%
Mill Road Capital Management LLC 14,896$236,0000.30%
Gs Investments, Inc. 15,800$250,746,0000.21%
RBF Capital, LLC 87,917$1,395,0000.18%
North Star Investment Management Corp. 85,282$1,353,0000.18%
CRAWFORD INVESTMENT COUNSEL INC 297,675$4,724,0000.16%
Uniplan Investment Counsel, Inc. 145,677$2,311,0000.16%
DEPRINCE RACE & ZOLLO INC 282,186$4,478,0000.13%
Moors & Cabot, Inc. 37,932$605,0000.10%
View complete list of PSYCHEMEDICS CORP shareholders